SCHEMBL25580601

SCHEMBL25580601

c1ccc(-c2ccccc2-c2c(-c3ccccc3)cccc2-c2ccc(N(c3ccc(-c4ccc5ccccc5c4)cc3)c3ccc4c(c3)oc3ccccc34)cc2)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HCRTR1 O43613 1/20 0.34
▸ HSD17B1 P14061 2/20 0.33
▸ HSD17B2 P37059 2/20 0.33
▸ ANO1 Q5XXA6 1/20 0.33
▸ MMP12 P39900 1/20 0.33
▸ MMP13 P45452 1/20 0.33
▸ PLA2G2A P14555 2/20 0.33
▸ PLA2G4A P47712 2/20 0.33
▸ GPR84 Q9NQS5 2/20 0.33
▸ PGR P06401 1/20 0.33
▸ AHR P35869 1/20 0.33
▸ ALDH1A1 P00352 2/20 0.32
▸ MAPT P10636 2/20 0.32
▸ ALOX5 P09917 1/20 0.32
▸ MEN1 O00255 2/20 0.32
▸ KMT2A Q03164 2/20 0.32
▸ KDM4E B2RXH2 1/20 0.32
▸ HPGD P15428 1/20 0.32
▸ THRB P10828 1/20 0.32
▸ RECQL P46063 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25580888 0.97 HCRTR1 (0.34) HCRTR1HSD17B1HSD17B2ANO1MMP12
SCHEMBL25580749 0.97 HCRTR1 (0.35) HCRTR1HSD17B1HSD17B2ANO1MMP12
SCHEMBL25580653 0.96 AHR (0.34) HCRTR1GPR84AHRALDH1A1MAPT
SCHEMBL25581019 0.95 HCRTR1 (0.35) HCRTR1HSD17B1HSD17B2ANO1MMP12
SCHEMBL23180788 0.94 PLA2G2A (0.37) HCRTR1HSD17B1HSD17B2ANO1MMP12
SCHEMBL24841345 0.94 PLA2G2A (0.37) HCRTR1HSD17B1HSD17B2ANO1MMP12
SCHEMBL25580598 0.94 ANO1 (0.35) HSD17B1HSD17B2ANO1PLA2G2APLA2G4A
SCHEMBL25580255 0.93 HSD17B1 (0.32) HCRTR1HSD17B1HSD17B2ANO1MMP12
SCHEMBL25578886 0.93 ANO1 (0.34) HCRTR1HSD17B1HSD17B2ANO1MMP12
SCHEMBL25578900 0.93 ANO1 (0.34) HCRTR1HSD17B1HSD17B2ANO1MMP12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230180597-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-06-08 — — US disclosed
US-20230180597-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-06-08 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230180597-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE ESR1, L1CAM, ESR2 HCRTR1 3385/4885HSD17B1 3017/4885HSD17B2 2771/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback